SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-057760
Filing Date
2023-11-02
Accepted
2023-11-02 08:03:50
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20230930.htm   iXBRL 10-Q 2897945
2 EX-10.1 gern-ex10_1.htm EX-10.1 109674
3 EX-10.2 gern-ex10_2.htm EX-10.2 110142
4 EX-31.1 gern-ex31_1.htm EX-31.1 17745
5 EX-31.2 gern-ex31_2.htm EX-31.2 17774
6 EX-32.1 gern-ex32_1.htm EX-32.1 9188
7 EX-32.2 gern-ex32_2.htm EX-32.2 9104
  Complete submission text file 0000950170-23-057760.txt   9744368

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230930_lab.xml EX-101.LAB 413623
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230930.xsd EX-101.SCH 49762
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20230930_def.xml EX-101.DEF 180819
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230930_pre.xml EX-101.PRE 287973
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20230930_cal.xml EX-101.CAL 46554
47 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230930_htm.xml XML 1959836
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 231370174
SIC: 2834 Pharmaceutical Preparations